- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01314703
Topical Antimicrobial Effectiveness Testing
October 30, 2012 updated by: CareFusion
Test for Preoperative Skin Preparations
The primary objective of this study is to measure the antimicrobial effectiveness of ChloraPrep one-Step.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Sterling, Virginia, United States, 20164
- Microbiotest
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- in good general health
- have skin within 6 inches of the test sites that is free of tattoos, dermatoses, abrasions, cuts, lesions or other skin disorders.
Exclusion Criteria:
- topical or systemic antimicrobial exposure within 14 days prior to Screening Day
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Antimicrobial Efficacy Will be Measured by the Change (+/-) in Bacterial Count on the Skin 10 Minutes After a Single Application of Test Material Relative to the Baseline Bacterial Count.
Time Frame: 10 minutes after single application of test material
|
the measure of antimicrobial efficacy was calculated by subtracting the 10 minute post test material application bacterial recovery from the baseline bacterial recovery.
|
10 minutes after single application of test material
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Muhammad H Bashir, MD, Microbiotest
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Actual)
April 1, 2011
Study Completion (Actual)
April 1, 2011
Study Registration Dates
First Submitted
March 10, 2011
First Submitted That Met QC Criteria
March 11, 2011
First Posted (Estimate)
March 14, 2011
Study Record Updates
Last Update Posted (Estimate)
November 1, 2012
Last Update Submitted That Met QC Criteria
October 30, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- 371.1.02.15.11
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Antimicrobial Effectiveness
-
CareFusionCompleted
-
Virginia Commonwealth UniversityCompletedEffectiveness of Antimicrobial Impregnated Scrubs in a Healthcare SettingUnited States
-
Tan Tock Seng HospitalNational University Hospital, Singapore; Khoo Teck Puat Hospital; Changi General...CompletedAntimicrobial ResistanceSingapore
-
Gama Healthcare Ltd.Completed
-
Tan Tock Seng HospitalNational Healthcare Group Polyclinics; Temasek PolytechnicCompletedAntimicrobial ResistanceSingapore
-
Laikο General Hospital, AthensUnknown
-
University of UlsterMerck Sharp & Dohme LLC; Northern Health and Social Care TrustNot yet recruitingAntimicrobial Stewardship
-
Chinese University of Hong KongCompletedAntimicrobial ResistanceHong Kong
-
Assistance Publique - Hôpitaux de ParisUnknownAntimicrobial ResistanceFrance
-
Onze Lieve Vrouw HospitalUniversity GhentCompletedAntimicrobial Treatment
Clinical Trials on ChloraPrep One-Step
-
CareFusionCompleted
-
Mansoura UniversityRecruitingDental Caries Class II | Marginal Integrity of Composite Restorations With Universal AdhesivesEgypt
-
TIJEN PAMIRActive, not recruitingDental Caries, Dental Pulp Exposure
-
Centre Hospitalier Annecy GenevoisUniversity Hospital, GrenobleCompletedST Elevation Myocardial InfarctionFrance
-
University of AarhusAarhus University Hospital; Sygehus LillebaeltRecruitingIrritable Bowel Syndrome | Fibromyalgia | Chronic Fatigue Syndrome | Bodily Distress Disorder Moderate | Bodily Distress Disorder Severe | SomatizationDenmark
-
3MCompletedBacterial Recovery of Skin Flora Post-product Application
-
University of AarhusWithdrawnIrritable Bowel Syndrome | Fibromyalgia | Somatization Disorder | Chronic Fatigue Syndrome | Bodily Distress Disorder Moderate
-
Eisai Co., Ltd.CompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
3MCompletedBacterial Reduction Post-product ApplicationUnited States